182 related articles for article (PubMed ID: 24721431)
21. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
22. Investigation of xenotropic murine leukemia virus-related virus (XMRV) in human and other cell lines.
Williams DK; Galvin TA; Ma H; Khan AS
Biologicals; 2011 Nov; 39(6):378-83. PubMed ID: 21996050
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.
Paprotka T; Venkatachari NJ; Chaipan C; Burdick R; Delviks-Frankenberry KA; Hu WS; Pathak VK
J Virol; 2010 Jun; 84(11):5719-29. PubMed ID: 20335265
[TBL] [Abstract][Full Text] [Related]
24. Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.
Culig Z; Hoffmann J; Erdel M; Eder IE; Hobisch A; Hittmair A; Bartsch G; Utermann G; Schneider MR; Parczyk K; Klocker H
Br J Cancer; 1999 Sep; 81(2):242-51. PubMed ID: 10496349
[TBL] [Abstract][Full Text] [Related]
25. Absence of XMRV and closely related viruses in primary prostate cancer tissues used to derive the XMRV-infected cell line 22Rv1.
Das Gupta J; Luk KC; Tang N; Gaughan C; Klein EA; Kandel ES; Hackett J; Silverman RH
PLoS One; 2012; 7(5):e36072. PubMed ID: 22615748
[TBL] [Abstract][Full Text] [Related]
26. AT-101 (R-(-)-gossypol acetic acid) enhances the effectiveness of androgen deprivation therapy in the VCaP prostate cancer model.
McGregor N; Patel L; Craig M; Weidner S; Wang S; Pienta KJ
J Cell Biochem; 2010 Aug; 110(5):1187-94. PubMed ID: 20589722
[TBL] [Abstract][Full Text] [Related]
27. In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancer.
Lee D; Das Gupta J; Gaughan C; Steffen I; Tang N; Luk KC; Qiu X; Urisman A; Fischer N; Molinaro R; Broz M; Schochetman G; Klein EA; Ganem D; Derisi JL; Simmons G; Hackett J; Silverman RH; Chiu CY
PLoS One; 2012; 7(9):e44954. PubMed ID: 23028701
[TBL] [Abstract][Full Text] [Related]
28. Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor-axis in castration-resistant prostate tumors.
Thomas C; Wafa LA; Lamoureux F; Cheng H; Fazli L; Gleave ME; Rennie PS
Prostate; 2012 Jun; 72(8):875-85. PubMed ID: 22072572
[TBL] [Abstract][Full Text] [Related]
29. XMRV accelerates cellular proliferation, transformational activity, and invasiveness of prostate cancer cells by downregulating p27(Kip1).
Pandhare-Dash J; Mantri CK; Gong Y; Chen Z; Dash C
Prostate; 2012 Jun; 72(8):886-97. PubMed ID: 21932423
[TBL] [Abstract][Full Text] [Related]
30. NF-kappaB activation stimulates transcription and replication of retrovirus XMRV in human B-lineage and prostate carcinoma cells.
Sakakibara S; Sakakibara K; Tosato G
J Virol; 2011 Apr; 85(7):3179-86. PubMed ID: 21270144
[TBL] [Abstract][Full Text] [Related]
31. Expression of BNIP3 correlates with hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha and the androgen receptor in prostate cancer and is regulated directly by hypoxia but not androgens in cell lines.
Shaida N; Launchbury R; Boddy JL; Jones C; Campo L; Turley H; Kanga S; Banham AH; Malone PR; Harris AL; Fox SB
Prostate; 2008 Feb; 68(3):336-43. PubMed ID: 18163427
[TBL] [Abstract][Full Text] [Related]
32. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
Gnanapragasam VJ; Robson CN; Neal DE; Leung HY
Oncogene; 2002 Aug; 21(33):5069-80. PubMed ID: 12140757
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of xenotropic murine leukemia virus-related virus infection in different risk populations in Spain.
Arredondo M; Hackett J; de Bethencourt FR; Treviño A; Escudero D; Collado A; Qiu X; Swanson P; Soriano V; de Mendoza C
AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1089-94. PubMed ID: 22206583
[TBL] [Abstract][Full Text] [Related]
34. 1alpha,25-Dihydroxyvitamin D3 down-regulates expression of prostate specific membrane antigen in prostate cancer cells.
Serda RE; Bisoffi M; Thompson TA; Ji M; Omdahl JL; Sillerud LO
Prostate; 2008 May; 68(7):773-83. PubMed ID: 18247401
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of insulin-like growth factor-binding protein 3 by 5-fluorouracil (5-FU) leads to the potent anti-proliferative effect of androgen deprivation therapy combined with 5-FU in human prostate cancer cell lines.
Kawabata R; Oie S; Takahashi M; Kanayama H; Oka T; Itoh K
Int J Oncol; 2011 Jun; 38(6):1489-500. PubMed ID: 21455575
[TBL] [Abstract][Full Text] [Related]
36. No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe.
Stieler K; Schindler S; Schlomm T; Hohn O; Bannert N; Simon R; Minner S; Schindler M; Fischer N
PLoS One; 2011; 6(10):e25592. PubMed ID: 22022417
[TBL] [Abstract][Full Text] [Related]
37. Antagonistic interaction between bicalutamide (Casodex) and radiation in androgen-positive prostate cancer LNCaP cells.
Quéro L; Giocanti N; Hennequin C; Favaudon V
Prostate; 2010 Mar; 70(4):401-11. PubMed ID: 19902473
[TBL] [Abstract][Full Text] [Related]
38. Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation.
Cardoso HJ; Figueira MI; Vaz CV; Carvalho TMA; Brás LA; Madureira PA; Oliveira PJ; Sardão VA; Socorro S
Cell Oncol (Dordr); 2021 Apr; 44(2):385-403. PubMed ID: 33464483
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of cellular determinants required for in vitro xenotropic murine leukemia virus-related virus entry into human prostate cancer and noncancerous cells.
Bhosle S; Suppiah S; Molinaro R; Liang Y; Arnold R; Diehl W; Makarova N; Blackwell J; Petros J; Liotta D; Hunter E; Ly H
J Virol; 2010 Jul; 84(13):6288-96. PubMed ID: 20410264
[TBL] [Abstract][Full Text] [Related]
40. Androgen stimulates transcription and replication of xenotropic murine leukemia virus-related virus.
Dong B; Silverman RH
J Virol; 2010 Feb; 84(3):1648-51. PubMed ID: 19906923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]